Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids.
Kugler A, Stuhler G, Walden P, Zöller G, Zobywalski A, Brossart P, Trefzer U, Ullrich S, Müller CA, Becker V, Gross AJ, Hemmerlein B, Kanz L, Müller GA, Ringert RH. Kugler A, et al. Among authors: brossart p. Nat Med. 2000 Mar;6(3):332-6. doi: 10.1038/73193. Nat Med. 2000. Retraction in: Nat Med. 2003 Sep;9(9):1221. doi: 10.1038/nm0903-1221a PMID: 10700237 Retracted. Clinical Trial.
Immunotherapy with dendritic cells for cancer.
Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A. Ballestrero A, et al. Among authors: brossart p. Adv Drug Deliv Rev. 2008 Jan 14;60(2):173-83. doi: 10.1016/j.addr.2007.08.026. Epub 2007 Oct 5. Adv Drug Deliv Rev. 2008. PMID: 17977615 Review.
The use of dendritic cells in cancer immunotherapy.
Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Among authors: brossart p. Crit Rev Oncol Hematol. 2008 Mar;65(3):191-9. doi: 10.1016/j.critrevonc.2007.10.002. Epub 2007 Dec 4. Crit Rev Oncol Hematol. 2008. PMID: 18055210 Review.
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
von Lilienfeld-Toal M, Frank S, Leyendecker C, Feyler S, Jarmin S, Morgan R, Glasmacher A, Märten A, Schmidt-Wolf IG, Brossart P, Cook G. von Lilienfeld-Toal M, et al. Among authors: brossart p. Cancer Immunol Immunother. 2010 Jun;59(6):829-39. doi: 10.1007/s00262-009-0807-3. Epub 2009 Dec 19. Cancer Immunol Immunother. 2010. PMID: 20024547 Free PMC article.
355 results